Circulation. 2000;101:e91
(Circulation. 2000;101:e91.)
© 2000 American Heart Association, Inc.
Circulation Electronic Pages |
Long-Term Results of Percutaneous Balloon Mitral Valvuloplasty Using the Inoue Balloon Catheter Technique
Tsung O. Cheng, MD
Professor of Medicine The George Washington University,
Washington, DC
 |
Introduction
|
|---|
To the Editor:
I read with interest the article on long-term follow-up after
percutaneous mitral valvuloplasty with the Inoue
balloon catheter by Hernandez et al.1 They reported a
restenosis rate of 39% at 7 years.
My colleagues from China and I recently reported our experience with
the same technique in a follow-up study up to 11 years in the first 202
patients2 among the original 4832 patients treated in
China.3 The restenosis rate was 8%, which is very
respectable and actually better than that after surgical closed
commissurotomy (25% to 28%).2 Why the restenosis
rate in the Chinese patients is much lower than that in the Spanish
patients is unclear.
Our experience as well as a series of recent reports of excellent
long-term results have strengthened the previous conclusion that
percutaneous mitral valvuloplasty using the Inoue
balloon technique should be the procedure of first choice in most
patients with mitral stenosis worldwide.4
 |
References
|
|---|
-
Hernandez R, Bañuelos C, Alfonso F, Goicolea
J, Fernández-Ortiz A, Escaned J, Azcona L, Almeria C, Macaya C.
Long-term clinical and echocardiographic follow-up
after percutaneous mitral valvuloplasty with the Inoue
balloon. Circulation. 1999;99:15801586.[Abstract/Free Full Text]
-
Chen C-R, Cheng TO, Chen J-Y, Huang Y-G, Huang T,
Zhang B. Long-term results of percutaneous balloon
mitral valvuloplasty for mitral stenosis: a follow-up study to
11 years in 202 patients. Cathet Cardiovasc Diagn. 1998;43:132139.[Medline]
[Order article via Infotrieve]
-
Chen C, Cheng TO, for the Multicenter Study Group.
Percutaneous balloon mitral valvuloplasty using Inoue
technique: a multicenter study of 4832 patients in China. Am
Heart J. 1995;129:11971204.[Medline]
[Order article via Infotrieve]
-
Cheng TO, Holmes DR Jr. Percutaneous
balloon mitral valvuloplasty by the Inoue balloon technique: the
procedure of choice for treatment of mitral stenosis.
Am J Cardiol. 1998;81:624628.[Medline]
[Order article via Infotrieve]
Response
Rosa Hernandez, MD;
Camino Bañuelos, MD;
Fernando Alfonso, MD;
Javier Goicolea, MD;
Antonio Fernández-Ortiz;
Javier Escaned, MD;
Luis Azcona, MD;
Carlos Almeria, MD;
Carlos Macaya
Hospital Universitario San Carlos,
Madrid, Spain
 |
Introduction
|
|---|
Dr Cheng remarks on the discrepancy between the restenosis rate
reported
in our article
R1 (39% at 7 years) and that
reported by him
and his colleagues
R2 (8%) after
percutaneous valvuloplasty
with the Inoue balloon. They
speculate whether or not baseline
differences in Spanish and Chinese
populations may account for
such a striking difference.
We believe that this difference is more apparent that real. Our
restenosis rate after a mean follow-up of 39±23 months was
10%, rather similar to that reported by them (8% after 3.7±2.1
years). A different methodology may account for these differences: (1)
Our analysis took under consideration not only the incidence of
restenosis in the whole series, but the time after the
procedure as well. Kaplan-Meier curves for restenosis (defined
as loss of 50% of gain by Doppler
echocardiography) revealed a restenosis
rate of 4% at 3 years, 18% at 5 years, and 39% at 7 years. (2) In
our series, not all patients included in the restenosis
definition were severely symptomatic (only 30 of 56, or
53%, were in class III), a requisite included in the definition of
restenosis by Cheng et al.
Nevertheless, as suggested by Dr Cheng, there were several differences
in baseline populations. Our patients were older (54±13 versus 38±12
years) and more frequently in atrial fibrillation (57% versus 22%)
than those in the Chinese series. Although immediate and last follow-up
results are difficult to compare because we reported Doppler data
and Cheng et al reported hemodynamic data, the repeat
valvuloplasty rate was 1% and 2% in both series, and the mitral
replacement rate was 10% and 6% in the Spanish and Chinese series,
respectively.
We fully agree with Dr Cheng that at the present time,
percutaneous mitral valvuloplasty with the Inoue
balloon is the treatment of choice for most patients with
symptomatic mitral stenosis worldwide.
 |
References
|
|---|
-
Hernandez R, Bañuelos C, Alfonso F, Goicolea
J, Fernández-Ortiz A, Escaned J, Azcona L, Almería C,
Macaya C. Long-term clinical and echocardiographic
follow-up after percutaneous mitral valvuloplasty with
the Inoue balloon. Circulation. 1999;99:15801586.
-
Chen CR, Cheng TO, Chen JY, Huang YG, Huang T, Zhang
B. Long-term results of percutaneous balloon mitral
valvuloplasty for mitral stenosis: a follow-up study to 11
years in 202 patients. Cath Cardiovasc Diagn.. 1998;43:132139.